These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34243699)

  • 1. Molecular docking and simulation studies of flavonoid compounds against PBP-2a of methicillin-resistant
    Verma AK; Ahmed SF; Hossain MS; Bhojiya AA; Mathur A; Upadhyay SK; Srivastava AK; Vishvakarma NK; Barik M; Rahaman MM; Bahadur NM
    J Biomol Struct Dyn; 2022; 40(21):10561-10577. PubMed ID: 34243699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention of methicillin susceptibility in Staphylococcus aureus using natural adjuvant as an allosteric modifier of penicillin-binding protein 2a.
    Islam MR; Azmal M; Prima FS; Zaman B; Hossain MM; Mishu MA; Ghosh A
    Comput Biol Med; 2024 Oct; 181():109070. PubMed ID: 39205340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic basis for the action of new cephalosporin antibiotics effective against methicillin- and vancomycin-resistant Staphylococcus aureus.
    Fuda C; Hesek D; Lee M; Heilmayer W; Novak R; Vakulenko SB; Mobashery S
    J Biol Chem; 2006 Apr; 281(15):10035-41. PubMed ID: 16459335
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Tabassum R; Kousar S; Mustafa G; Jamil A; Attique SA
    Biomed Res Int; 2023; 2023():5100400. PubMed ID: 37250750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.
    Kuok CF; Hoi SO; Hoi CF; Chan CH; Fong IH; Ngok CK; Meng LR; Fong P
    Exp Biol Med (Maywood); 2017 Apr; 242(7):731-743. PubMed ID: 28118725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis of pyridine coupled pyrimidinone/pyrimidinthione as anti-MRSA agent: Validation by molecular docking and dynamics simulation.
    Nanjundaswamy S; Bindhu S; Arun Renganathan RR; Nagashree S; Karthik CS; Mallu P; Ravishankar Rai V
    J Biomol Struct Dyn; 2022; 40(22):12106-12117. PubMed ID: 34424132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, in-silico studies and biological screening of quinazolinone analogues as potential antibacterial agents against MRSA.
    Qureshi SI; Chaudhari HK
    Bioorg Med Chem; 2019 Jun; 27(12):2676-2688. PubMed ID: 31103406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics.
    Villegas-Estrada A; Lee M; Hesek D; Vakulenko SB; Mobashery S
    J Am Chem Soc; 2008 Jul; 130(29):9212-3. PubMed ID: 18582062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methicillin-resistant Staphylococcus aureus. Mechanisms of resistance and implications for treatment.
    Chambers HF
    Postgrad Med; 2001 Feb; 109(2 Suppl):43-50. PubMed ID: 19667557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Lactam Antibiotics with a High Affinity for PBP2 Act Synergistically with the FtsZ-Targeting Agent TXA707 against Methicillin-Resistant Staphylococcus aureus.
    Ferrer-González E; Kaul M; Parhi AK; LaVoie EJ; Pilch DS
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico exploration of 4(α-l-rhamnosyloxy)-benzyl isothiocyanate: A promising phytochemical-based drug discovery approach for combating multi-drug resistant Staphylococcus aureus.
    Bhattacharya S; Dutta A; Khanra PK; Gupta N; Dutta R; Tzvetkov NT; Milella L; Ponticelli M
    Comput Biol Med; 2024 Sep; 179():108907. PubMed ID: 39033680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New sulphonamide-peptide hybrid molecules as potential PBP 2a ligands and methicillin resistant
    Ibezim A; Onuku R; Ottih C; Ezeonu I; Onoabedje E; Ramanathan K; Nwodo N
    J Biomol Struct Dyn; 2023; 41(14):6684-6694. PubMed ID: 35975581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of Geranyl acetate against cell wall synthesis proteins of
    Manjunath A; Chinmayi GVA; Renganathan S; Chandramohan V; Sabat S
    J Biomol Struct Dyn; 2024 Apr; 42(6):3030-3050. PubMed ID: 37199273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No relationship exists between PBP 2a amounts expressed in different MRSA strains obtained clinically and their beta-lactam MIC values.
    Parvez MA; Shibata H; Nakano T; Niimi S; Fujii N; Arakaki N; Higuti T
    J Med Invest; 2008 Aug; 55(3-4):246-53. PubMed ID: 18797139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-Silico molecular screening of natural compounds as a potential therapeutic inhibitor for Methicillin-resistant Staphylococcus aureus inhibition.
    Nandhini P; Gupta PK; Mahapatra AK; Das AP; Agarwal SM; Mickymaray S; Alothaim AS; Rajan M
    Chem Biol Interact; 2023 Apr; 374():110383. PubMed ID: 36754228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBP 2a mutations producing very-high-level resistance to beta-lactams.
    Katayama Y; Zhang HZ; Chambers HF
    Antimicrob Agents Chemother; 2004 Feb; 48(2):453-9. PubMed ID: 14742194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of penicillin-binding protein 2a (PBP2a) in methicillin resistant Staphylococcus aureus (MRSA) by combination of ampicillin and a bioactive fraction from Duabanga grandiflora.
    Santiago C; Pang EL; Lim KH; Loh HS; Ting KN
    BMC Complement Altern Med; 2015 Jun; 15():178. PubMed ID: 26060128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular docking study of sappan wood extract to inhibit PBP2A enzyme on methicillin-resistant Staphylococcus aureus (MRSA).
    Gondokesumo ME; Kurniawan IM
    J Basic Clin Physiol Pharmacol; 2020 Jan; 30(6):. PubMed ID: 31953996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PBP 4 Mediates High-Level Resistance to New-Generation Cephalosporins in Staphylococcus aureus.
    Chan LC; Gilbert A; Basuino L; da Costa TM; Hamilton SM; Dos Santos KR; Chambers HF; Chatterjee SS
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3934-41. PubMed ID: 27067335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomistic simulation on flavonoids derivatives as potential inhibitors of bacterial gyrase of
    Ramachandran B; Srinivasadesikan V; Chou TM; Jeyakanthan J; Lee SL
    J Biomol Struct Dyn; 2022 Jul; 40(10):4314-4327. PubMed ID: 33308046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.